Common Stock, Shares, Outstanding of Chemomab Therapeutics Ltd. from 31 Dec 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Chemomab Therapeutics Ltd. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • Chemomab Therapeutics Ltd. Common Stock, Shares, Outstanding for the quarter ending 30 Jun 2025 was 413,851,140, a 44% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 413,851,140 +126,667,340 +44% 30 Jun 2025 6-K 14 Aug 2025 2025 Q2
Q4 2024 377,132,220 +93,037,520 +33% 31 Dec 2024 6-K 14 Aug 2025 2025 Q2
Q2 2024 287,183,800 +39,125,100 +16% 30 Jun 2024 6-K 21 Aug 2024 2024 Q2
Q4 2023 284,094,700 +51,458,000 +22% 31 Dec 2023 6-K 21 Aug 2024 2024 Q2
Q2 2023 248,058,700 +19,425,580 +8.5% 30 Jun 2023 6-K 14 Aug 2023 2023 Q2
Q1 2023 232,636,700 +4,546,400 +2% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 232,636,700 +4,546,400 +2% 31 Dec 2022 6-K 14 Aug 2023 2023 Q2
Q3 2022 229,015,402 +1,059,342 +0.46% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 228,633,120 +677,060 +0.3% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 228,090,300 +14,130,360 +6.6% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 228,090,300 +218,815,462 +2359% 31 Dec 2021 10-Q 10 Nov 2022 2022 Q3
Q3 2021 227,956,060 +190,856,708 +514% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 227,956,060 +190,856,708 +514% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 213,959,940 +176,860,588 +477% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 9,274,838 -27,824,514 -75% 31 Dec 2020 10-Q 12 Nov 2021 2021 Q3
Q3 2020 37,099,352 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 37,099,352 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 37,099,352 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 37,099,352 +21,523,670 +138% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q4 2018 15,575,682 31 Dec 2018 10-K 17 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.